Dr Yasar Yousafzai

  • Honorary Research Fellow (School of Infection & Immunity)

email: Yasar.Yousafzai@glasgow.ac.uk

Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Phase-5, Hayatabad, Peshawar, 25000

Import to contacts

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2016
Number of items: 9.

2022

Shah, S., Khan, A., Shahzad, M., Mokhtar, J. A., Harakeh, S., Kibria, Z., Mehr, A., Bano, B., Ali, A. and Yousafzai, Y. M. (2022) Determinants of response at 2 months of treatment in a cohort of Pakistani patients with pulmonary tuberculosis. Antibiotics, 11(10), 1307. (doi: 10.3390/antibiotics11101307) (PMID:36289965) (PMCID:PMC9598398)

Khan, M. N. et al. (2022) Seroprevalence of Sars-Cov-2 antibodies among eligible blood donors of Peshawar, Pakistan. American Journal of Blood Research, 12(3), pp. 88-96. (PMID:35873102) (PMCID:PMC9301020)

Mehmood, M., Usman Khan, H., Khan, M. I., Khan, I., Al-Raddadi, R. M., Harakeh, S. and Yousafzai, Y. M. (2022) Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients. Infectious Diseases, 54(6), pp. 460-463. (doi: 10.1080/23744235.2022.2033312) (PMID:35147051)

2021

Ahmad, N., Qayum, S., Jameel, A., Ali, A., Siraj, S., Ali, J. and Yousafzai, Y. M. (2021) Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients. Pakistan Journal of Pharmaceutical Sciences, 34(6(Sup)), pp. 2289-2295. (doi: 10.36721/PJPS.2021.34.6.SUP.2289-2295.1) (PMID:35039265)

2020

Abdelrasoul, H. et al. (2020) Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature Communications, 11, 3194. (doi: 10.1038/s41467-020-16927-w) (PMID:32581241) (PMCID:PMC7314847)

2019

Yousafzai, Y. M. et al. (2019) Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leukemia Research, 87, 10623. (doi: 10.1016/j.leukres.2019.106232) (PMID:31706196)

2018

Ali, A., Ali, Z., Yousafzai, Y. M. and Oien, K. A. (2018) Cancer biomarker development from basic science to clinical practice. Journal of Postgraduate Medical Institute, 32(1), pp. 3-8.

Bartram, J., Goulden, N., Wright, G., Adams, S., Brooks, T., Edwards, D., Inglott, S., Yousafzai, Y., Hubank, M. and Halsey, C. (2018) High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica, 103, e113. (doi: 10.3324/haematol.2017.174987) (PMID:29217777)

2016

Williams, M. T.S. et al. (2016) The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukaemia blasts. Blood, 127, 16. (doi: 10.1182/blood-2015-08-665034) (PMID:26869395)

This list was generated on Sun Apr 27 07:10:16 2025 BST.
Jump to: Articles
Number of items: 9.

Articles

Shah, S., Khan, A., Shahzad, M., Mokhtar, J. A., Harakeh, S., Kibria, Z., Mehr, A., Bano, B., Ali, A. and Yousafzai, Y. M. (2022) Determinants of response at 2 months of treatment in a cohort of Pakistani patients with pulmonary tuberculosis. Antibiotics, 11(10), 1307. (doi: 10.3390/antibiotics11101307) (PMID:36289965) (PMCID:PMC9598398)

Khan, M. N. et al. (2022) Seroprevalence of Sars-Cov-2 antibodies among eligible blood donors of Peshawar, Pakistan. American Journal of Blood Research, 12(3), pp. 88-96. (PMID:35873102) (PMCID:PMC9301020)

Mehmood, M., Usman Khan, H., Khan, M. I., Khan, I., Al-Raddadi, R. M., Harakeh, S. and Yousafzai, Y. M. (2022) Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients. Infectious Diseases, 54(6), pp. 460-463. (doi: 10.1080/23744235.2022.2033312) (PMID:35147051)

Ahmad, N., Qayum, S., Jameel, A., Ali, A., Siraj, S., Ali, J. and Yousafzai, Y. M. (2021) Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients. Pakistan Journal of Pharmaceutical Sciences, 34(6(Sup)), pp. 2289-2295. (doi: 10.36721/PJPS.2021.34.6.SUP.2289-2295.1) (PMID:35039265)

Abdelrasoul, H. et al. (2020) Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature Communications, 11, 3194. (doi: 10.1038/s41467-020-16927-w) (PMID:32581241) (PMCID:PMC7314847)

Yousafzai, Y. M. et al. (2019) Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leukemia Research, 87, 10623. (doi: 10.1016/j.leukres.2019.106232) (PMID:31706196)

Ali, A., Ali, Z., Yousafzai, Y. M. and Oien, K. A. (2018) Cancer biomarker development from basic science to clinical practice. Journal of Postgraduate Medical Institute, 32(1), pp. 3-8.

Bartram, J., Goulden, N., Wright, G., Adams, S., Brooks, T., Edwards, D., Inglott, S., Yousafzai, Y., Hubank, M. and Halsey, C. (2018) High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica, 103, e113. (doi: 10.3324/haematol.2017.174987) (PMID:29217777)

Williams, M. T.S. et al. (2016) The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukaemia blasts. Blood, 127, 16. (doi: 10.1182/blood-2015-08-665034) (PMID:26869395)

This list was generated on Sun Apr 27 07:10:16 2025 BST.